To Download a copy of the presentation click here.
To Download a copy of the updated Q&A Responses click here.
Moderator:
Dana S. Wollins, DrPH, MGC
Senior Vice President, Strategy
Infectious Diseases Society of America
Topics
HPAI Update
Jay Butler, MD, FIDSA
Deputy Director for Infectious Diseases
U.S. Centers for Disease Control and Prevention
Epidemiology of Clade II Mpox
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer
Poxvirus and Rabies Branch
U.S. Centers for Disease Control and Prevention
Update on Mpox Vaccinations
Meghan Pennini, PhD
Chief Vaccines and Therapeutics Officer
HHS Coordination Operations and Response Element (H-CORE)
Administration for Strategic Preparedness and Response
U.S. Department of Health and Human Services
Update on Tecovirimat EA-IND Eligibility Criteria for Treatment for Mpox
Patty Yu, MPH
Regulatory Health Scientist
U.S. Centers for Disease Control and Prevention
Q&A and Discussion — All Presenters Plus:
Robert Goldstein, MD, PhD
Commissioner
Massachusetts Department of Public Health
Boghuma K. Titanji, MD, MSc, DTM&H, PhD
Assistant Professor of Medicine
Emory University School of Medicine
Timothy Wilkin, MD
Assistant Dean for Clinical Research Compliance
Weill Cornell Medical College
